The variability in clinical features and the masking effects of drug therapy in Parkinson's disease (PD) can affect clinical assessment of disease severity. The aim of this study was to assess the imaging of dopamine transporters using 123 I-FP-CIT SPECT and its correlation with disease staging, sev
β¦ LIBER β¦
Baseline [ 123 I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
β Scribed by Nissen, T.; Malek, N.; Grosset, K. A.; Newman, E. J.; Patterson, J.; Hadley, D.; Grosset, D. G.
- Book ID
- 121717042
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 140 KB
- Volume
- 129
- Category
- Article
- ISSN
- 0001-6314
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Correlation of Parkinson's disease sever
β
Hani T. S. Benamer; Jim Patterson; David J. Wyper; Donald M. Hadley; G. J. A. Ma
π
Article
π
2000
π
John Wiley and Sons
π
English
β 98 KB
π 1 views
Parkinson's disease is overdiagnosed cli
β
Vicky L. Marshall; Cornelia B. Reininger; Moritz Marquardt; Jim Patterson; Donal
π
Article
π
2009
π
John Wiley and Sons
π
English
β 125 KB
## Abstract Overdiagnosis of Parkinson's disease (PD) is suggested by specialist review of community diagnosis, and in postmortem studies. In specialist centers 4 to 15% of patients entered into clinical trials as early PD do not have functional imaging support for a PD diagnosis. In a European mul
Progression of dopaminergic degeneration
β
Sean J. Colloby; E. David Williams; David J. Burn; Jim J. Lloyd; Ian G. McKeith;
π
Article
π
2005
π
Springer
π
English
β 213 KB